|
Dr. Merril is the Chair of the Company's Scientific Advisory Board.
He is a leading expert and innovator in high-resolution two-dimensional protein electrophoresis, to search for abnormal biochemical pathways and genomic alterations in diseases that affect the central nervous system
Dr. Merril has published more than 200 scientific papers, is an inventor on nearly two dozen patents, and has been the recipient of numerous awards for his scientific and administrative achievements. Dr. Merril was at the National Institutes of Health from 1963 to 2005 and was most recently Chief, Laboratory of Biochemical Genetics at the National Institute of Mental Health.
Dr. Merril is founder and CEO of Hygea BioPharma, Inc., Gaithersburg, MD. Dr. Merril is an Adjunct Professor in Biochemistry and Genetics at George Washington University and an Adjunct member of the graduate faculty of the University of Maryland.
Dr. Merril is an Editorial Board member of the journals Analytical Biochemistry and Insight and formerly of BioTechniques. He also served as the Editor-In-Chief of Applied and Theoretical Electrophoresis and he was the Senior Associate Editor of the journal Electrophoresis.
He served as President of both the International Electrophoresis Society and the American Electrophoresis Societies and as Chairman of the Surgeon General's Advisory Panel for the Research Officer Group. He also served on the Alzheimer's Association's Initial Review Board of the Medical and Scientific Advisory Council. | 